BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8960614)

  • 1. Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion.
    Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
    Am J Perinatol; 1996 Oct; 13(7):437-41. PubMed ID: 8960614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
    Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M
    Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
    Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
    Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution.
    Hershkovitz R; Erez O; Sheiner E; Landau D; Mankuta D; Mazor M
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):22-7. PubMed ID: 12580835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome.
    Gravett CP; Buckmaster JG; Watson PT; Gravett MG
    Am J Med Genet; 1992 Nov; 44(4):485-6. PubMed ID: 1279970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated maternal serum hCG in the second trimester increases prematurity rate and need for neonatal intensive care in primiparous preeclamptic pregnancies.
    Heikkilä A; Makkonen N; Heinonen S; Kirkinen P
    Hypertens Pregnancy; 2001; 20(1):99-106. PubMed ID: 12044318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between risk factors for fetal growth retardation associated with abnormal umbilical artery Doppler studies.
    Spinillo A; Bergante C; Gardella B; Mainini R; Montanari L
    Acta Obstet Gynecol Scand; 2004 May; 83(5):431-5. PubMed ID: 15059153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexplained elevated maternal serum beta-HCG concentration and adverse pregnancy outcome.
    Ganapathy R; Lamont RF; Bassett P
    Prenat Diagn; 2007 Nov; 27(11):995-9. PubMed ID: 17621365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Velamentous umbilical cord insertion may be suspected from maternal serum alpha-fetoprotein and hCG.
    Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
    Br J Obstet Gynaecol; 1996 Mar; 103(3):209-13. PubMed ID: 8630303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
    Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
    Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-trimester serum chorionic gonadotropin concentrations and complications and outcome of pregnancy.
    Walton DL; Norem CT; Schoen EJ; Ray GT; Colby CJ
    N Engl J Med; 1999 Dec; 341(27):2033-8. PubMed ID: 10615074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
    Vega J; Sáez G; Smith M; Agurto M; Morris NM
    Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal diagnostic evaluation of velamentous umbilical cord insertion: clinical, Doppler, and ultrasonic findings.
    Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
    Obstet Gynecol; 1996 Jan; 87(1):112-7. PubMed ID: 8532244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical coiling index in normal and complicated pregnancies.
    de Laat MW; Franx A; Bots ML; Visser GH; Nikkels PG
    Obstet Gynecol; 2006 May; 107(5):1049-55. PubMed ID: 16648410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal growth in patients with elevated maternal serum hCG levels.
    Tanaka M; Natori M; Kohno H; Ishimoto H; Kobayashi T; Nozawa S
    Obstet Gynecol; 1993 Mar; 81(3):341-3. PubMed ID: 8437782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quad screen as a predictor of adverse pregnancy outcome.
    Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of ultrasound to detect small-for-gestational-age infants in patients with elevated human chorionic gonadotropin on maternal serum screening.
    Hatfield T; Caughey AB; Lagrew DC; Heintz R; Chung JH
    Am J Perinatol; 2010 Feb; 27(2):173-80. PubMed ID: 19742421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.